Article
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers
7 Apr 2023
Abstract excerpt
OBJECTIVE: Chordomas are rare bone neoplasms characterized by a high recurrence rate and no benefit from any approved medical treatment to date. However, the investigation of molecular alterations in chordomas could be essential to prognosticate, guide clinical decision-making, and identify theranostic biomarkers. The aim of this study was to provide a detailed genomic landscape of a homogeneous series of 64...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
